Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Depression 3Polycystic Ovary Syndrome 2Depressive Disorder, Major 2Neoplasms 1Lymphoma, Follicular 1Head and Neck Neoplasms 1Asthma 1

Interventions

Fluticasone-Salmeterol Drug Combination 2Fluticasone 2Diclofenac 2ziconotide 1secukinumab 1ropinirole 1aliskiren 1acetaminophen, codeine drug combination 1Venlafaxine Hydrochloride 1Thiotepa 1Tacrolimus 1Sublocade 1Ribavirin 1Radiotherapy 1Quinine 1Oxycodone 1Naloxone 1Ketamine 1Furosemide 1Filgrastim 1Fentanyl 1Escitalopram 1Donepezil 1Cyclophosphamide 1Buprenorphine, Naloxone Drug Combination 1Bimatoprost 1Artesunate 1Antilymphocyte Serum 1Amoxicillin-Potassium Clavulanate Combination 1Amlodipine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Lymphoma, Follicular × Escitalopram × Clear all
NCT00621946 2014-02-04

Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder

University of Texas Southwestern Medical Center

Phase 4 Completed
26 enrolled 13 charts
Lymphoid

Asthma, Depression, Depressive Disorder, Major, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡